[Erectile dysfunction as a harbinger of cardiovascular events. Long-term vascular protection with telmisartan].
Arnheim
Katharina
K
D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use*; D050197:Atherosclerosis / Q000188:drug therapy; D001562:Benzimidazoles / Q000627:therapeutic use*; D001565:Benzoates / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000175:diagnosis / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D018783:Impotence, Vasculogenic / Q000188:drug therapy* / Q000209:etiology*; D008297:Male; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D000077333:Telmisartan
D047228:Angiotensin II Type 1 Receptor Blockers; D001562:Benzimidazoles; D001565:Benzoates; D000077333:Telmisartan